- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01478906
Difference of Plasma Orexin A Levels Between Elderly and Young Patients at Emergence
To Investigate Difference of Plasma Orexin A Levels Between Elderly and Youth Patients at Emergence From Sevoflurane-fentanyl Anesthesia Undergoing Elective Lumbar Surgery
연구 개요
상태
정황
상세 설명
BACKGROUND:A specific group of neurons in the brain produces hypocretin, also called orexin, a peptide which has been established as an important regulator of anesthesia and emergence in the latest few years. In the animal experiment,we found that the level of orexin A in aged rats was higher when compared with that of the young ones. Whereas the numbers of both the orexin receptor 1 and 2 in aged rats decreased. We wonder if there is a similar phenomenon in human beings which might account for the difference between the intervals of elderly and young patients recovering from anesthesia. This study aims to investigate difference of plasma orexin A levels between elderly patients and young at emergence from sevoflurane-fentanyl anesthesia.
DESIGNING:Forty patients with ASA physical status I or II scheduled for elective lumbar surgery under general anesthesia (lasting for 2h to 4h)were enrolled. Anesthesia was induced with propofol 1-1.5mg/kg and fentanyl 2-3μg/kg. Following muscle relaxation with iv rocuronium bromide 1mg/kg endotracheal intubation was performed. Anesthesia was maintained with sevoflurane(inhalational concentration: 0.8-1.5 MAC) fentanyl (total 6μg/kg) and target controlled infusion remifentanil (targeted concentration:2-7ng/ml ) along with an oxygen/air mixture (FiO2 = 0.5). Muscle relaxation was maintained with intermittent rocuronium. Inhalational concentration of sevoflurane and injected target concentration were titrated to maintain the bispectral index (BIS) between 45 and 65 during anesthesia. The end-tidal carbon dioxide level was maintained between 30 and 40mmHg by controlled mechanical ventilation. When the surgery was complicated we adjust the concentration sevoflurane to 0.8MAC of the patient and targeted concentration of remifentanil to 2ng/ml and then stop all anesthetics . Record time from stopping anesthetics to emergence. Arterial blood (2ml) was collected at the following time, such as before and 1h after induction of anesthesia, at emergence (1min after tracheal extubation) and half an hour after tracheal extubation. This was centrifuged at 3000 rpm for 15min at -4 ◦C in order to separate plasma then stored at -80 ◦C until assay for orexin A concentrations.
EXPECTED RESULTS:The plasma orexin A of group elderly will be higher with the emergence time longer than youth patients.
연구 유형
등록 (예상)
연락처 및 위치
연구 장소
-
-
Shaanxi
-
Xi'an, Shaanxi, 중국, 710032
- 모병
- Anesthesiology department of Xijing Hospital
-
연락하다:
- Zhihua Wang, postgraduate
- 전화번호: 86-2984775343
- 이메일: xiangrikui038@sohu.com
-
수석 연구원:
- Hailong Dong, MD,PhD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Participant is Adult (≥18 years old )
- Participants with a Body Mass Index (BMI) 20-25 kg/m2 at the prestudy (screening) visit.
- Participants with ASA physical status Ⅰor Ⅱ
- Participants with Heart function rating Ⅰor Ⅱ
- Glucose of patients is lower than 8 mmol/L
- patients will undergo elective lumbar surgery
Exclusion Criteria:
- Participant is a pregnant woman or a nursing mother.
- Participants have a history of narcotics allergic reactions
- indices of liver or kidney function is twice higher than normal
- Participants have a history or diagnosis of depression
- Participants have a history of Brain Trauma
- Participants have a history of narcotics addiction or drug addiction
- Participants have a history or diagnosis of adrenal gland diseases
- Participants or his family have an International Classification of Sleep Disorders diagnosis of OSA
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 시간 관점: 유망한
코호트 및 개입
그룹/코호트 |
|---|
|
elderly ,adult
|
공동 작업자 및 조사자
스폰서
수사관
- 연구 책임자: Hailong Dong, MD,PhD, Xijing Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- mzk2010orexin
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .